Screening different host cell lines for the dynamic production of measles virus

Tanja A Grein1, Felix Schwebel1, Marco Kress1

  • 1Inst. of Bioprocess Engineering and Pharmaceutical Technology, Faculty of Live Science Engineering, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, Giessen, 35390, Germany.

Biotechnology Progress
|January 6, 2017
PubMed

Insights

Optimizing measles virus (MV) production for cancer therapy requires efficient host cells. Vero cells in stirred tank reactors, monitored by dielectric spectroscopy, yielded high oncolytic MV titers.

Area of Science:

  • Biotechnology
  • Virology
  • Chemical Engineering

Background:

  • Oncolytic measles virus (MV) shows promise for cancer treatment due to its natural affinity for cancer cells.
  • Large-scale production of MV is a bottleneck for clinical application, requiring high virus yields.
  • Host cell choice and cultivation methods significantly impact virus production.

Purpose of the Study:

  • To investigate host cell productivity for oncolytic MV production.
  • To optimize virus yield by evaluating different cell lines and cultivation systems.
  • To implement online monitoring for critical process control during MV production.

Main Methods:

  • Screening of different host cells (Vero, BJAB) for MV productivity.
  • Comparison of static (T-flask) and dynamic (stirred tank reactor) cultivation systems.
  • Utilizing dielectric spectroscopy for online monitoring of infection and harvest times.

Main Results:

  • Vero and BJAB cells showed high initial productivity, but only Vero cells maintained high yields in stirred tank reactors.
  • Dielectric spectroscopy enabled precise control over infection and harvest.
  • Vero cells in stirred tank reactors achieved higher titers (up to 1011 TCID50 ml-1) compared to static systems.

Conclusions:

  • Vero cells are highly productive for oncolytic MV in dynamic cultivation systems.
  • Online monitoring with dielectric spectroscopy is crucial for optimizing MV production.
  • This optimized process can significantly increase the yield of oncolytic MV for cancer therapy.

Related Concept Videos